Perspectives in Pancreatic Pain by Salim, A. S.
HPB Surgery, 1997, Vol. 10, pp. 269-277
Reprints available directly from the publisher
Photocopying permitted by license only
(C) 1997 OPA (Overseas Publishers Association)
Amsterdam B.V. Published in The Netherlands
by Harwood Academic Publishers
Printed in India
Perspectives in Pancreatic Pain
A. S. SALIM
Department of Surgery, National University of Malaysia, Jalan Raja Muda, Kuala Lumpur, Malaysia
(Received 25 October 1993)
This review describes some of the mechanisms
which are thought to be important in the causation
of pain in chronic pancreatitis. Both medical and
surgical techniques for treating this pain are
described.
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INTRODUCTION
Chronic pancreatitis is not a simple disease
entity but an expression of multiple diseases
such as alcoholism, tropical malnutrition, hyper-
parathyroidism, hyperlipidaemia, hereditary
predisposition and ductal obstruction. Geo-
graphical differences in the incidence and
natural history of this disease are clearly
observed. In each case the anatomical deformi-
ties must be individually assessed with the
operative choices and techniques, if indicated,
remaining flexible and adaptable.
Chronic pancreatitis is characterized by both
the persistence and the relentless progression of
pancreatic lesions in contrast to acute pancre-
atitis where the pancreatic lesions usually
resolve. The natural history of chronic pancrea-
titis is punctuated by recurring episodes of acute
inflammation. According to the Marseilles clas-
sification, this has been termed relapsing or
recurrent chronic pancreatitis, however it is
customary nowadays to identify pancreatitis
only as acute or chronic [1, 2]. The inflammatory
process initially affects and destroys the exo-
crine tissue and then the islets of Langerhans,
however the functional reserve capacity of the
pancreas is so great that clinically significant
pancreatic insufficiency does not occur until
more than 85% of functioning tissue is lost [1].
Then malabsorption, steatorrhoea, and insulin-
dependent diabetes ensue. Pancreatic calcifica-
tion, usually evident on a plain upper abdominal
radiograph, occurs in 30-50% of patients.
Possible complications include malabsorption,
weight loss, diabetes mellitus, ascites and/or
pleural effusion, narrowing of the common bile
duct, duodenum and/or colon, left-sided portal
hypertension following thrombosis of the splen-
ic, superior mesenteric and/or portal veins,
major arterial haemorrhage, and pain [1]. In-
tractable abdominal pain is a feature in more
than 95% of patients with chronic pancreatitis [1].
THE PATHOLOGY OF CHRONIC
PANCREATITIS
Chronic alcoholism is the most common cause of
chronic pancreatitis in the Western World.
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Because only about 10% of alchoholics develop
the disease, it may be that a certain predisposing
factor, perhaps a hereditary disorder exposed by
an environmental or nutritional influence, in-
creases susceptibility to the disease. The pan-
creatic juice in patients with alcohol-induced
chronic pancreatitis has an additional protein,
lactoferrin, which has a molecular weight
of 69000 daltons and is slightly anionic at
pH8.611]. This protein is associated with the
formation of acidic macromolecules and com-
plexes whichmay be a key factor in the formation
of the protein precipitates noted in the ducts of
alcoholic patients with chronic pancreatitis [1].
The lesions of this disease may progress through
a precalcifying stage to eventual clacification and
stone formation [1]. Microscopically, the earliest
changes appear to be precipitates of proteinac-
eous material in the intercalated and canalicular
ductules. Later on calcium carbonate is added to
the glycoprotein plugs leading to the character-
istic calcifications, a process enhanced by the
increased secretion of ionized calcium in the
pancreatic juice of the alcohol-induced chronic
pancreatitis patient [1]. The ductular obstruction
caused by the protein plugs is associated with
small ductular cavities lined by cuboidal epithe-
lium and containing pancreatic juice, debris,
necrotic matter or blood. In addition, the plugs
cause ductular dilatation, which is followed by
acinar atrophy [1]. A variable inflammatory in-
filtrate may occur in the interstitium with fibrosis
within and between the lobules and around the
ducts [1]. At the final stages, the pancreas is
replaced by fibrous tissue with a few nests of
acinar tissue and some islet cells [1]. The ducts are
usually widely dilated with pseudosacculations
and interspersed areas of dilatation and stenosis
(a chain of lakes). It is not uncommon, however,
to see normal ducts.
Obstructive chronic pancreatitis can be caused
by fibrosis of the ampulla of Vater, papillary
inflammation, congenital or acquired strictures
of the main duct, and pancreatic paranchymal
tumours. Following ductal obstruction, diffuse
lesions with no lobular topography appear and
spare no exocrine tissue [1]. The ductal caliber
remains regular with no alternating stenosis and
dilatation. The major ducts are dilated modera-
tely, while the finer branches have normal
diameters. The ductal epithelium is intact, the
duct lumina are empty, and protein plugs as
well as calcifications are rare [1]. Nevertheless,
many patients with chronic pancreatitis have
normal-sized or even narrowed ducts.
Surgical management of the disease is influ-
enced by duct size [3]. Patients with ducts
enlarged to 8 mm or more in diameter are
considered for a drainage procedure to relieve
pain. Conversely, patients with smaller ducts are
candidates for resection. Moreover, there is
some evidence that the natural history of the
disease and the likelihood of complications may
be different depending on whether the patient
has small or large duct disease. Nealon and co-
workers [4] described 93 patients with chronic
pancreatitis (22 with small ducts and 71 with
large ducts) who were evaluated prospectively.
Of the 71 with large ducts, 43 underwent pan-
creaticojejunostomy. A total of 75 patients were
assessed 14 months later. They concluded that
patients with small duct chronic pancreatitis
deteriorated functionally more slowly than those
with unoperated large duct chronic pancreatitis.
Those with large duct chronic pancreatitis who
underwent operation did better than either of
the other 2 groups.
About one third of patients with calcifying
chronic pancreatitis develop jaundice from
common duct compression at some time during
their disease. Two clinical situations are recog-
nized: (a) During an acute episode of pancreatic
inflammation, the bile duct is compressed by the
swollen head of pancreas. (b) In about 2% of
cases jaundice is due to fibrotic narrowing of the
common bile duct [5]. Most often there is a
diffuse, longitudinal, symmetrical stricture of
the intrapancreatic portion of the common bile
duct with minimal dilatation of the duct
proximally. The obstruction is almost neverPANCREATIC PAIN 271
complete. The gallbladder and cystic duct may
be dilated but usually much less than with
cancer [5]. Less, commonly, there is an hourglass
shaped narrowing localized at the upper border
of the pancreas. This type is rarely associated
with jaundice [5].
Cysts and pseudocysts are also seen in chronic
pancreatitis [1]. True cysts are produced by
ductal obstruction with continued pancreatic
juice secretion into the duct. They start as
dilatations of the pancreatic ductules which
enlarge and break into the peripancreatic tissue
forming ill-defined cystic collections surrounded
by a reactionary sclerosis. At this stage such cysts
are no longer lined by epithelium and are
pseudocysts. With continued pancreatic necrosis
there may rupture into the peripancreatic spaces
forming a fibrous tissue lined cavity surrounded
and limited by the neighboring organs.
Chronic pancreatitis may lead to duodenal and
colonic obstruction [6]. The inflammatory pan-
creatic exudate containing active enzymes and
other toxic substances reaches theduodenum and
colon through their peritoneal and mesenteric
attachments [6]. The duodenal fibrosis may also
be due to ischaemia superimposed on inflamma-
tory oedema. Many of the arteries and nerves
supplying the duodenum pass first through
pancreatic tissue and are susceptible to injury
during pancreatic inflammation. The colonic
involvement depends on the site bearing the
brunt of chronic pancreatitis. Disease in the head
and body of the pancreas may affect the trans-
verse colon; disease in the tail of the pancreasmay
involve the splenic flexure. Histological examina-
tion of the obstructed segment of colon shows
chronic inflammatory fibrosis and spread of
inflammatory exudate to the vessels causing
vascular thrombosis and colonic ischaemia.
Blood vessels are also affected by chronic
pancreatitis where the smaller arteries within
the gland become increasingly tortuous and
beaded and the larger arteries outside the gland
may be dstroyed by activated proteolytic
enzymes leading to haemorrhage. The veins
are also involved and while splenic vein occlu-
sion is usually recognized, involvement of the
superior mesenteric and portal veins may be
overlooked perhaps until unexpected varices are
seen during laparotomy.
Chronic pancreatitis causes changes in the
pancreatic nerves manifested by inflammation
and destruction of the perineural sheath thus
rendering the nerve exposed to irritants (pan-
creatic enzymes and kinins). These changes
are particularly important due to their relation-
ship to the mechanism of pain in chronic
pancreatitis.
PANCREATIC PAIN
Pain is a prominent feature of both acute and
chronic pancreatitis as well as pancreatic cancer.
The natural history of chronic pancreatitis is
punctuated by recurring episodes of acute
inflammation which are manifested by severe
abdominal pain. This pain poses considerable
management problems because it may prove to
be difficult to treat and lead to narcotic addiction
and significant psychological disturbances. Con-
sequently, serious socio-economical problems
become an added dimension in the manage-
ment of these patients. The success of medical
management of the pain may fail unless patients
give up alcohol completely which may need the
support of special clinics. Intractable pain may
call for total pancreatectomy after the patient has
completely given up alcohol, an operation
which, in other than the most experienced
hands, is likely to have an unacceptable mortal-
ity and morbidity [3, 7-9]. Any measure that
can safely control, or at least reduce, pancreati-
tis-induced pain will have far reaching social
and economical advantages besides obvious
medical implications.
Pancreatitis-induced abdominal pain is
thought to be multifocal in origin and most
commonly caused by increased intraductal
pressure, fibrosis or inflammation around peri-272 A.S. SALIM
pancreatic nerves, or acute inflammatory epi-
sodes [7]. The role of intraductal pressure in the
mechanism of pain was initially supported
by intraoperative and later by endoscopic
measurements. Japanese investigators using an
endoscopic technique found higher intraductal
pressure in patients with painful chronic pan-
creatitis than in those in whom it was painless
[10]. It has also been established that a close
correlation exists between tissue pressure and
pain in patients with Chronic pancreatitis who
underwent drainage operations. A substantial
reduction in pressure after drainage was fol-
lowed by pain relief and this pressure was noted
to increase once again when the pain recurred
[8, 9]. The neural changes occurring in chronic
pancreatitis (increase in the number of nerves in
inflammatory pancreatic tissue and degenera-
tion of the perineurium) allow an influx of
inflammatory mediators and activated pan-
creatic enzymes to play a role in the mechanism
of pain [1, 7, 8]. The possibility exists that the
increased pressure and the neuritis operate
synergistically to produce the pancreatitis-in-
duced pain. The high tissue fluid pressure may
facilitate influx of inflammatory mediators into
the nerves. The acute episodes of pain that occur
in the early stages of typical chronic pancreatitis
might be related to recurrent autodigestive
necrosis and enlargement of pseudocysts. Since
the magnitude and duration of pain cannot be
correlated with the morphological changes in
the gland, it has been proposed that the pain
may be associated with the dynamics of the
disease rather than with the static situation [8, 9].
MEDICAL MANAGEMENT
OF PANCREATIC PAIN
The treatment of this symptom has not changed
significantly over the past few years. Apart from
insisting on total abstinence from alcohol, the
treatment of pancreatic pain includes analgesia
(narcotic or non-narcotic agents alone or with
NSAIDs) with or without tricyclic anti-depres-
sants, anti-neoplastic agents, prednisolone and
pancreatic enzyme supplements [8]. These sup-
plements relieve pain via the effect of trypsin on
pancreatic secretion. The lack of trypsin activity
within the intestinal lumen causes hyperstimula-
tion of the gland by cholecystokinin, and perhaps
also by cholinergic pathways, which might lead
to high intraductal and tissue pressure and pain.
Restoration of intestinal trypsin may enhance
pain relief [8]. On the basis of the duct tissue-
hypertension theory, endoscopic stenting of the
main pancreatic duct in chronic pancreatitis, and
the dorsal duct in pancreas divisum, has been
used to relieve pain. This approach, however,
fails to overcome outflow obstruction from
secondary or tertiary ducts and is thereby unable
to completely relieve the pain [11, 12].
Most of the sensory nerves to the pancreas
pass through the coeliac ganglion and splanch-
nic nerves. In patients with pancreatitis whose
exocrine and endocrine functions have already
been compromised, nerve ablation procedures
by the percutaneous injection of anaesthetic
agents, ethanol, or phenol have been used to
obtain pain relief [13]. The results of these
procedures, however, have been disappointing
with no more than half .of the treated cases
obtaining pain relief for about two months [13].
Conversely, coeliac plexus chemoneurolysis
should be considered in pancreatic cancer more
often than it is today, and at an earlier stage [8].
Regardless of the cause of episodes of pan-
creatic pain one of the feature of chronic pan-
creatitis is a continuous inflammatory process
with round cell infiltration[I]. Since oxygen-
derived free radicals are cytotoxic agents that
produce tissue damage and inflammation [7, 14],
and since these radicals are released by oxida-
tive bursts from inflammatory cells [15], it may
well be that they mediate the mechanism of
pancreatic pain and its recurrent episodes.
Nonaka et al. [16] confirmed that free radicals
are a key factor in the development of acute
pancreatitis in experimental animals [17] andPANCREATIC PAIN 273
reported that the imbalance between the offense
system represented by xanthine oxidase and
lipid peroxide and the defense system reflected
by superoxide dismutase might be an important
cause of tissue damage induced by free radicals.
In man [7], administration of radical scavengers
such as allopurinol and dimethyl sulphoxide
(DMSO) significantly increased the efficacy of
narcotic analgesics in the treatment of recurrent
episodes of pancreatitis-induced pain and signi-
ficantly reduced white cell counts and lactate
dehydrogenase levels. The serum lactate dehy-
drogenase is a measurement of the amount of
tissue destruction and may reflect the magni-
tude of pancreatic and peripancreatic inflamma-
tion and necrosis [18] and the white cell count is
a measure of the local tissue reaction. One of the
major gains attained by the use of radical
scavengers was the accelerated discharge of
patients from the surgical unit. Although DMSO
directly scavenges hydroxyl radicals it also
inhibits inflammatory cell functions [19]. These
cells can participate in the process of tissue
injury by oxidative bursts which yield reactive
oxygen species[19] and since these cells also
mediate the inflammation associated with the
recurring episodes of chronic pancreatitis, the
possibility exists that DMSO might have com-
bated free radicals to a greater or lesser extent
by inhibiting inflammatory cell functions.
A proportion of patients have an anxiety
syndrome partly manifested as abdominal pain
which may be controlled with appropriate
support and anti-depressant treatment.
Results of pain control or the lack of it have to
be based on objective parameters of assessment
and in this regard linear analogue scales of pain
severity are helpful.
SURGICAL PROCEDURES
FOR PAIN RELIEF
Surgery may help two thirds of the patients
obtain pain relief provided the surgical pro-
cedure is carefully chosen. Thus, duct decom-
pression operations are designed to reduce duct-
tissue pressure while saving the paranchyma in
patients with a dilated main pancreatic duct
whereas resectional surgery removes the origin
of pain by excising inflammatory, necrotic,
fibrotic or cystic tissue. Surgery is therefore
offered for symptomatic relief and not correction
of glandular malfunction.
A distinction has to be made between ob-
structive chronic pancreatitis due to inflamma-
tory or tumoural occlusion of the pancreatic
ducts, which can be cured by treatment of the
obstruction, and chronic calcifying pancreatitis
resulting in irreversible sclerosis of the pan-
creatic paranchyma with or without dilatation of
the ducts and the possible development of
intrapancreatic pseudocysts, biliary or duodenal
stenosis, and sometimes portal hypertension.
The natural history of chronic pancreatitis
usually proceeds through four phases:
1. a latency period which may extend for many
years.
2. a clinically-active stage lasting 3-5 years
manifested by recurrent pain and acute crises
with possible development of pseudocysts.
3. an intermediate stage lasting about 5 years
during which the pain decreases in intensity
and frequency.
4. a late stage where pain usually disappears
but diabetes is found in 80% of the surviving
cases.
Mortality in patients with chronic pancreatitis
is higher than in the general population with
25-50% of cases dying 10 years after the clinical
phase has commenced [20]. This aspect of the
disease has to be taken into consideration in
relation to the expected survival gain that might
accure from operative intervention. Evaluation
must include knowledge of the operative
mortality, quality of functional results, and re-
operation rate. As drug addiction is one of the
disheartening consequences of severe pancreatic
pain, surgery for the pain should be offered well274 A.S. SALIM
before the patient becomes a narcotic addict and
before the patient develops nutritional or meta-
bolic disturbances. The weight of clinical evi-
dence, however, does not lend support to the
concept that pancreatic function improves fol-
lowing decompressive operations [9].
Nerve ablation procedures by surgical splan-
chnicectomy and coeliac ganglionectomy to inter-
rupt sensory innervation of the pancreas are
technically demanding due to access limitations
and have been replaced by percutaneous chemo-
neurolysis but with very minimal gains. Surgical
nerve ablation may, nonetheless, be considered as
an alternative after a failed drainage or resection.
Operations on the sphincter of Oddi and the
sphincter of Wirsung are .suitable for those very
rare cases that have a localized ampullary
stenosis leading to a uniformly dilated pancrea-
tic duct. It is unlikely that chronic pancreatitis is
responsible for this stenosis which is probably a
sequelae of complicated choledocholithectomy.
It is possible, however, that endoscopic sphinc-
terotomy in association with external lithotripsy
to eliminate pancreatic stones may radicaly
modify present treatment of chronic calcifying
pancreatitis.
Pancreaticojejunostomy is well established as
an effective ductal drainage procedure provided
the main pancreatic duct is dilated. Side-to-side
pancreaticojejunostomy is the method of choice
because its longer anastomosis is thought to be
crucial in providing long-term drainage and
pain relief. This procedure has the advantage of
saving pancreatic glandular tissue in addition to
having low morbidity and mortality rates. The
anastomosis should ideally be at least 8 cm long
to avoid stenosis at a later date. In addition,
retaining the spleen eliminates the risk of
postsplenectomy sepsis. The proportion of pa-
tients becoming completely or partially pain-free
averages 70% and this relates inversely to the
length of the postoperative period, however the
majority of cases still experience pain relief after
5 years [9]. This response is promoted by
complete abstinence from alcohol intake.
It remains to be seen whether ductal drainage
by pancreaticogastrostomy [21] offers any addi-
tional advantages in terms of pain relief over
those already afforded by pancreaticojejuno-
stomy.
Triple bypass, consisting of pancreaticojeju-
nostomy with choledochojejunostomy and gas-
trojejunostomy, without pancreatic resection is
associated with technical complexity and opera-
tive risk similar to those of pancreaticoduo-
denectomy and incurs more failures and
reoperations. A review of this operation showed
a mortality rate of 4.5% and after 2 years the
survival rate was 78% with 85% of the cases
having good functional results but 13% of the
patients requiring reoperation [22]. Attempts to
avoid marginal ulceration by biliary, pancreatic
and duodenal diversion using interposition of
an isolated jejunal loop between the pancreatic
duct and the jejunum are yet to be confirmed
independently [20].
Refinements of endoscopic techniques may
enable a wider use in the future of endoscopic
methods to treat chronic pancreatitis particu-
larly cystogastrostomy for pseudocysts [20].
Resective procedures in chronic pancreatitis
remove part or all of the pancreas to achieve
pain relief. The best results of resection are seen
when the head of the gland is removed in
patients with major involvement of this part of
the gland, intractable pain, and absence of
dilated pancreatic ducts. The classical Whipple
pancreaticoduodenectomy operation is still the
most commonly used procedure under these
circumstances, but other operations that pre-
serve the stomach and duodenum have been
introduced and detailed assessment of their
exact role in the treatment of chronic pan-
creatitis-pain is eagerly awaited [8, 9]. The
mortality and morbidity rates of the Whipple
procedure continue to be high in other than
experienced hands, thus it is recommended that
the selection and treatment of patients must be
carried out in specialty centres familiar with this
type of surgery.PANCREATIC PAIN 275
Left resections of the pancreatic gland have
been suggested. The initial promising results of
80% pain relief reported by Fry et al. [23]
following 95% left-sided pancreatic resection
were, unfortunately, reduced to 56% after a
mean follow-up of 7.8 years. A major additional
problem was the high incidence of diabetes and
late deaths (27%) mainly related to metabolic
disturbances caused by the extent of resection.
These disappointing results have also been
noted by others [8, 9], thus there is little
enthusiasm today to carry out this type of
surgery. Pain is seldom the main reason for
operation in pancreatic carcinoma, however the
palliative value of pancreaticoduodenal resec-
tion must not be overlooked in patients who are
not curable but have resectable primary lesions
and a few metastases in the regional lymph-
nodes and/or liver. Once again the emphasis
has to be on carrying out this operation in
specialist centres to reduce risks. Although total
pancreatectomy aims to remove the source of
pain, it still carries the risk of operative mortality
with difficulties in endocrine control and may
not succeed in affording complete pain re-
lief[8,9]. Thus, the dismal results of this pro-
cedure and its high early and late morbidity
restrict its application in patients with chronic
pancreatitis.
NEW SURGICAL APPROACHES
The results of surgical treatment must be judged
primarily by the grade of pain relief measured
against the risks entailed. With this in mind,
there have been serious efforts to advance
surgical contribution to pain relief in the chronic
pancreatitis patient. Cuilleret and Guillemin [20]
reported satisfactory results with the Gauthier-
Benoit bipolar pancreatectomy where a pancrea-
ticoduodenectomy is performed in patients who
have previously undergone distal pancreatect-
omy preserving a small isthmic segment of the
pancreas for anastomosis to the jejunal loop. The
indications for this procedure remain excep-
tional and its exact role in the surgical manage-
ment of pancreatic pain is still to be defined. The
du0denum-preserving resection of the head of
pancreas as described by Beger and colleagues
[24] includes excision of the pancreatic head
apart from a rim between the duodenum and
bile duct at the inner curvature of the duo-
denum. The mesoduodenal vessels, and not
necessarily the gastroduodenal artery, must be
saved when resecting the uncinate process to
preserve the duodenal blood flow. The resected
end of the left pancreas is anastomosed to a
jejunal Roux loop which is also connected to the
small pancreatic remnant at the inner curvature
of the duodenum. In 57 patients, the hospital
mortality was 2% and 90% of these patients
continued to have significant pain relief 2 years
after surgery [24]. Frey and Smith [25] intro-
duced a similar approach for patients with
ductal dilatation and strictures and a markedly
enlarged fibrotic pancreatic head. The duct in
the corpus and cauda are opened and the
pancreatic head is cored out, leaving a rim of
glandular tissue along the inner aspects of the
duodenum and the bottom of the crater. A Roux
loop is anastomosed side-to-side to the opened
pancreatic duct as well as to the cored out head
of the gland. Frey and Smith reported 6 cases
with an uneventful postoperative course [25].
The effect on pain is less clear. The satisfactory
long-term effects and low morbidity of the
pylorus-preserving pancreaticoduodenectomy
and the good results with the duodenum-
preserving total pancreatectomy in infants for
nesidioblastosis led to the development of total
pancreatectomy with preservation of the whole
duodenum for advanced chronic pancreatitis
[26]. Fourteen adult patients were operated on
with no hospital mortality and no major post-
operative complications. Good pain relief was
noted in two-thirds of the patients besides
improved gastrointestinal function and easier
control of the diabetes [26]. Another operation
for chronic pancreatitis is the denervated pan-276 A.S. SALIM
creatic flap operation [27]. Following subtotal
resection of the pancreatic head the remaining
pancreas is mobilized from its bed while
vascularity is preserved via retrograde flow
from the splenic hilus. Five patients underwent
this procedure without mortality but 2 cases had
major postoperative complications. At 9 months,
3 of the 5 patients had good pain control. Larger
series of patients by various centers is a pre-
requisite before these new surgical procedures
can be adopted and gain a position among
current surgical strategies.
THE PRESENT POSITION
A consensus has been currently reached on the
role of surgery in the treatment of chronic
pancreatitis:
1. The natural history of the disease cannot be
influenced by surgical treatment which must
therefore play a palliative role with particular
emphasis on pain relief and prevention of
complications.
2. Total and subtotal pancreatectomy must be
used selectively due to their operative mor-
tality and their metabolic sequelae. Splanch-
nicectomy is no longer used alone for its
results are too uncertain. Distal pancreatect-
omy is performed only when the disease is
limited to the left part of the gland and even
then many surgeons add a pancreaticojeju-
nostomy.
3. Long-term survival and functional results
depend mainly on alcohol withdrawal, which
is a mandatory pre-requisite before any
elective surgical treatment.
Current trends in Europe include performing
fewer resections and more pancreaticojejunos-
tomies than 10 years ago [20]. Nonetheless,
pancreaticoduodenectomy, which has the ad-
vantage of treating or preventing almost all of
the complications of the disease thereby reduc-
ing the reoperation rate, still retains an impor-
tant role in cases with biliary or duodenal
involvement [20]. Another general trend is
toward minimizing, as far as possible, the
metabolic sequelae of surgery in order to
maintain nutritional status and provide the
patient with better digestive, function. In this
respect, several modifications of pancreatico-
duodenectomy, preserving the pylorus, have
been described.
Surgical management of chronic pancreatitis
remains a diffcult problem not only because of
the expected end results, but also because the
choice of the surgical procedure, the place of
operation in the course of disease, and even
the principle of operation remain actively
debated.
Acknowledgement
I am grateful to Mrs Jutta Gaskill for her skilful
secretarial work.
References
[1] Singh, S. M. and Reber, H. A. (1990). The pathology of
chronic pancreatitis. World J. Surg., 14, 2-10.
[2] Sarner, M. and Cotton, P. B. (1984). Classification of
pancreatitis. International Workshop, King’s College,
Cambridge, March 1983. Gut, 25, 756-759.
[3] ’Maclaren, I. F. (1990). Observations and surgical mana-
gement of chronic pancreatitis in the British Isles: a
review of the twentieth century. World J. Surg., 14,19- 27.
[4] Nealon, W. H., Townsend, C. M. Jr. and Thompson, J. C.
(1988). A comparison of large duct and small duct
variants in chronic pancreatitis. Pancreas, 3, 610-615.
[5] Sarles, H. and Sahel, J. (1978). Progress report: Choles-
tasis and lesions of the biliary tract in chronic
pancreatitis. Gut, 19, 851-853.
[6] Bradley, III Enteropathies, E. L. (1982). In: Comp-
lications of Pancreatitis: Medical and Surgical Manage-
ment. E. L. Bradley, III, Ed. Philadelphia, W. B. Saunders.
[7] Salim, A. S. (1991). Role of oxygen-derived free radical
scavengers in the treatment of recurrent pain produced
by chronic pancreatitis. A new approach. Arch. Surg.,
126, 1109-1114.
[8] Ihse, I. (1990). Pancreatic pain. Br. J. Surg., 77, 121-122.
[9] Ihse, I., Borch, K. and Larsson, J. (1990). Chronic
pancreatitis: results of operations for relief of pain.
World J. Surg., 14, 53-58.
[10] Okazaki, K., Yamamoto, Y. and Kagiyama, S. et al.
(1980). Pressure of papillary zone and pancreatic main
duct in patients with chronic pancreatitis in the early
state. Scand. J. Gastroenterol., 23, 501- 506.PANCREATIC PAIN 277
[11] Huibregtse, K., Schneider, B., Vrij, A. A. and Tytgat, G.
N. J. (1988). Endoscopic pancreatic drainage in chronic
pancreatitis. Gastrointest. Endosc., 34, 9-15.
[12] Kozarek, R. A., Patterson, D. J., Ball, T. J. and Traverso,
L. W. (1989). Endoscopic placement of pancreatic stents
and drains in the management of pancreatitis. Ann.
Surg., 209, 261-266.
[13] Leung, J. W. C., Browne-Wright, M., Aveling, W.,
Shorvon, P. J. and Cotton, P. B. (1983). Coeliac plexus
block for pain in pancreatic cancer and chronic
pancreatitis. Br. J. Surg., 70, 730-733.
[14] Del Maestro, R. F., Thaw, H. H., Bjork, Jo, Planker, M. and
Arfors, K. E. (1980). Free radicals as mediators of tissue
injury. Acta. Physiol. Scand., Suppl., 492, 43-57.
[15] Grisham, M. B. and Granger, D. N. (1988). Neutrophil-
mediated mucosal injury: role of reactive oxygen
metabolites. Dig. Dis. Sci., 33, (3rd Suppl.) 68-158.
[16] Nonaka, A., Manabe, T., Tamura, K., Asano, N.,
Imanishi, K. and Tobe, T. (1989). Changes in xanthine
oxidase, lipid peroxide and superoxide dismutase in
mouse acute pancreatitis. Digestion, 43, 41-46.
[17] Sanfey, H., Bulkley, G. B. and Cameron, J. L. (1985). The
pathogenesis of acute pancreatitis. The source and role
of oxygen-derived free radicals in three different
experimental models. Ann. Surg., 201, 633-639.
[18] Choi, T. K., Mok, F., Zhan, W. H., Fan, S. T., Lai, E. C. S.
and Wong, J. (1989). Somatostatin in the treat-ment of
acute pancreatitis: a prospective randomised controlled
trial. Gut, 30, 223-227.
[19] Beilke, M. A., Cathleen Collins-Lech and Solnle, P. G.
(1987). Effect of dimethyl sulfoxide on the oxidative
function of human neutrophils. J. Lab. Clin. Med., 110,
91-96.
[20]. Cuilleret, J. and Guillemin, G. (1990). Surgical manage-
ment of chronic pancreatitis on the continent of Europe.
World J. Surg., 14, 11-18.
[21] Pain, J. A. and Knight, M. J. (1988). Pancreaticogas-
trostomy: The preferred operation for pain relief in
chronic pancreatitis. Br. J. Surg., 7, 220-222.
[22] Gauthier-Benoit, C. and Perissat, J. (1987). Le traitement
des pancr6atites chroniques. Rapport au 896me Congr6s
de 1’ Association Francaise de Chirurgie, Paris, Masson.
[23] Frey, C. F., Child III, C. G. and Fry, W. (1976). Pancrea-
tectomyforchronicpancreatitis.Ann. Surg.,184, 403 406.
[24] Beger, H. G., Krautzberger, W., Bittner, R., Biichler, M.
and Limmer, J. Duodenum-preserving resection of the
head of the pancreas in patients with severe chronic
pancreatitis. Surgery, 97, 467-470.
[25] Frey, C. F. and Smith, G. J. (1987). Description and
rationale of a new operation for chronic pancreatitis.
Pancreas, 2, 701 706.
[26] Lambert, M. A., Linehan, J. P. and Russel, R. C. G.
(1987). Duodenum preserving, total pancreatectomy
for end stage chronic pancreatitis. Br. J. Surg., 74, 35-38.
[27] Shires III, G. T., Warren, W. D., Millikan, W. J.,
Henderson, J. M. and Hersh, T. (1986). Denervated
splenopancreatic flap for chronic pancreatitis. Ann.
Surg., 203, 568-570.